請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/94057完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 朱忠瀚 | zh_TW |
| dc.contributor.advisor | John Chu | en |
| dc.contributor.author | 林濬元 | zh_TW |
| dc.contributor.author | Jyun-Yuan Lin | en |
| dc.date.accessioned | 2024-08-14T16:28:29Z | - |
| dc.date.available | 2024-08-15 | - |
| dc.date.copyright | 2024-08-13 | - |
| dc.date.issued | 2024 | - |
| dc.date.submitted | 2024-08-09 | - |
| dc.identifier.citation | 1. O'Neill, J. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations; 2014.
2. US. Department of Health & Human Services 3. Pillonetto, M.; Arend, L.; Vespero Eliana, C.; Pelisson, M.; Chagas Thiago Pavoni, G.; Carvalho-Assef Ana Paula, D. A.; Asensi Marise, D. First report of NDM-1-producing Acinetobacter baumannii sequence type 25 in Brazil. Antimicrobial Agents and Chemotherapy 2014, 58, 7592-7594. 4. Tehrani, K. H. M. E.; Martin, N. I. β-lactam/β-lactamase inhibitor combinations: an update. MedChemComm 2018, 9, 1439-1456. 5. Wang, Y.; Zhang, R.; Li, J.; Wu, Z.; Yin, W.; Schwarz, S.; Tyrrell, J. M.; Zheng, Y.; Wang, S.; Shen, Z.; et al. Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production. Nature Microbiology 2017, 2, 16260. 6. Zhang, J.; Scott, W. R. P.; Gabel, F.; Wu, M.; Desmond, R.; Bae, J.; Zaccai, G.; Algar, W. R.; Straus, S. K. On the quest for the elusive mechanism of action of daptomycin: Binding, fusion, and oligomerization. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2017, 1865, 1490-1499. 7. Chambers, H. F.; DeLeo, F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nature Reviews Microbiology 2009, 7, 629-641. 8. Pourramezan, N.; Ohadian Moghadam, S.; Pourmand, M. R. Methicillin-resistant Staphylococcus aureus tracking spread among health-care workers and hospitalized patients in critical wards at a university hospital, Tehran, Iran. New Microbes and New Infections 2019, 27, 29-35. 9. Aminov, R. History of antimicrobial drug discovery: Major classes and health impact. Biochemical Pharmacology 2017, 133, 4-19. 10. Gwynn, M. N.; Portnoy, A.; Rittenhouse, S. F.; Payne, D. J. Challenges of antibacterial discovery revisited. Annals of the New York Academy of Sciences 2010, 1213, 5-19. 11. Grayson, M. L.; Cosgrove, S.; Crowe, S.; Hope, W.; McCarthy, J.; Mills, J.; Mouton, J. W.; Paterson, D. Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs; CRC Press, 2017. 12. Sauermann, R.; Rothenburger, M.; Graninger, W.; Joukhadar, C. Daptomycin: a review 4 years after first approval. Pharmacology 2008, 81, 79-91. 13. Wood, T. M.; Martin, N. I. The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry. MedChemComm 2019, 10, 634-646. 14. Debono, M.; Barnhart, M.; Carrell, C.; Hoffmann, J.; Occolowitz, J.; Abbott, B.; Fukuda, D.; Hamill, R.; Biemann, K.; Herlihy, W. A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation. The Journal of antibiotics 1987, 40, 761-777. 15. Strieker, M.; Marahiel, M. A. The structural diversity of acidic lipopeptide antibiotics. ChemBioChem 2009, 10, 607-616. 16. Mchenney, M. A.; Hosted, T. J.; Dehoff, B. S.; Rosteck Jr, P. R.; Baltz, R. H. Molecular cloning and physical mapping of the daptomycin gene cluster from Streptomyces roseosporus. Journal of bacteriology 1998, 180, 143-151. 17. Müller, A.; Wenzel, M.; Strahl, H.; Grein, F.; Saaki, T. N.; Kohl, B.; Siersma, T.; Bandow, J. E.; Sahl, H.-G.; Schneider, T. Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains. Proceedings of the National Academy of Sciences 2016, 113, E7077-E7086. 18. Beriashvili, D.; Taylor, R.; Kralt, B.; Abu Mazen, N.; Taylor, S. D.; Palmer, M. Mechanistic studies on the effect of membrane lipid acyl chain composition on daptomycin pore formation. Chemistry and Physics of Lipids 2018, 216, 73-79. 19. Zhang, J.; Scott, W. R.; Gabel, F.; Wu, M.; Desmond, R.; Bae, J.; Zaccai, G.; Algar, W. R.; Straus, S. K. On the quest for the elusive mechanism of action of daptomycin: Binding, fusion, and oligomerization. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 2017, 1865, 1490-1499. 20. Borders, D. B.; Leese, R. A.; Jarolmen, H.; Francis, N. D.; Fantini, A. A.; Falla, T.; Fiddes, J. C.; Aumelas, A. Laspartomycin, an acidic lipopeptide antibiotic with a unique peptide core. Journal of natural products 2007, 70, 443-446. 21. Naganawa, H.; Hamada, M.; Maeda, K.; Okami, Y.; Takeuchi, T.; Umezawa, H. Laspartomycin, a new anti-staphylococcal peptide. The Journal of Antibiotics 1968, 21, 55-62. 22. Diehl, A.; Wood, T. M.; Gebhard, S.; Martin, N. I.; Fritz, G. The cell envelope stress response of Bacillus subtilis towards Laspartomycin C. Antibiotics 2020, 9, 729. 23. Wood, T. M.; Bertheussen, K.; Martin, N. I. The contribution of achiral residues in the laspartomycin family of calcium-dependent lipopeptide antibiotics. Organic & Biomolecular Chemistry 2020, 18, 514-517. 24. Kotsogianni, I.; Wood, T. M.; Alexander, F. M.; Cochrane, S. A.; Martin, N. I. Binding Studies Reveal Phospholipid Specificity and Its Role in the Calcium-Dependent Mechanism of Action of Daptomycin. ACS Infect Dis 2021, 7, 2612-2619. 25. Kleijn, L. H.; Oppedijk, S. F.; ’t Hart, P.; van Harten, R. M.; Martin-Visscher, L. A.; Kemmink, J.; Breukink, E.; Martin, N. I. Total synthesis of laspartomycin C and characterization of its antibacterial mechanism of action. Journal of medicinal chemistry 2016, 59, 3569-3574. 26. Kleijn, L. H.; Vlieg, H. C.; Wood, T. M.; Sastre Toraño, J.; Janssen, B. J.; Martin, N. I. A High‐Resolution Crystal Structure that Reveals Molecular Details of Target Recognition by the Calcium‐Dependent Lipopeptide Antibiotic Laspartomycin C. Angewandte Chemie International Edition 2017, 56, 16546-16549. 27. Chiou, S. L.; Chen, Y. J.; Lee, C. T.; Ho, M. N.; Miao, J.; Kuo, P. C.; Hsu, C. C.; Lin, Y. S.; Chu, J. A Boron‐Dependent Antibiotic Derived from a Calcium‐Dependent Antibiotic. Angewandte Chemie International Edition 2024, 63, e202317522. 28. Jung, D.; Rozek, A.; Okon, M.; Hancock, R. E. Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chemistry & biology 2004, 11, 949-957. 29. Ball, L.-J.; Goult, C. M.; Donarski, J. A.; Micklefield, J.; Ramesh, V. NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin. Organic & biomolecular chemistry 2004, 2, 1872-1878. 30. TA instruments. Quick Start: Isothermal Titration Calorimetry (ITC); 2016. | - |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/94057 | - |
| dc.description.abstract | 拉斯帕托霉素C (Laspartomycin C, LspC) 是被最廣泛研究的鈣依賴型抗生素 (Calcium-dependent antibiotic, CDA)之一。在之前已有關於LspC的晶體研究,在研究中已經證實了LspC能與兩個鈣離子與香葉基單磷酸 (geranyl phosphate, C10-P) 穩定結合。然而,由於牽涉到兩個鈣離子結合的過程及構象轉變,以一般的熱力學研究方法,很難精確地描述整個過程。
在本實驗室之前的研究中,將LspC的相似物S1的兩個天門冬酸 (Aspartic acid, Asp) 改為絲胺酸 (Serine, Ser) ,成為能與苯硼酸(Phenylboronic acid, PBA) 結合之化合物 B1,並且在這篇研究中也利用生物實驗,證明了B1對於鈣離子的依賴性相較於S1大幅降低。 本次研究中,我們以B1能利用苯硼酸取代一個鈣離子的特性,將Laspartomycin C與兩個鈣離子結合的過程,簡化為一個苯硼酸及一個鈣離子的結合過程。我們也發現B1、PBA及C10-P需要同時存在,結合反應才能夠進行,是一件相當有趣的現象。在後續的實驗中也能以此為方向,對LspC的詳細結合過程做更深入的探討。 | zh_TW |
| dc.description.abstract | Laspartomycin C (LspC) is one of the most extensively studied calcium-dependent antibiotics (CDAs). Previous crystallographic studies have demonstrated that LspC can stably bind with two calcium ions and geranyl phosphate (C10-P). However, due to the involvement of two calcium ions and conformational changes, it is difficult to precisely describe the entire process using conventional thermodynamic methods. In our lab's previous research, the two aspartic acids (Asp) in the LspC analogue S1 were replaced with serine (Ser), creating compound B1, which can bind to phenylboronic acid (PBA). Biological experiments have shown that B1's dependency on calcium ions is significantly reduced compared to S1. In this study, we utilized B1's ability to replace one calcium ion with phenylboronic acid to simplify the process of LspC binding with two calcium ions into a process involving one phenylboronic acid and one calcium ion. We also discovered that B1, PBA, and C10-P must be present simultaneously for the binding reaction to occur, an interesting phenomenon. Future experiments can further explore the detailed binding process of LspC based on these findings. | en |
| dc.description.provenance | Submitted by admin ntu (admin@lib.ntu.edu.tw) on 2024-08-14T16:28:29Z No. of bitstreams: 0 | en |
| dc.description.provenance | Made available in DSpace on 2024-08-14T16:28:29Z (GMT). No. of bitstreams: 0 | en |
| dc.description.tableofcontents | 致謝 i
摘要 ii Abstract iii List of Contents iv List of Figures vi List of Tables x List of Schemes xi Abbreviations xii 1 Introduction 1 1.1 Background 1 1.2 Calcium-Dependent Antibiotics (CDAs) 2 1.3 Daptomycin 3 1.4 Laspartomycin C (LspC) 5 1.5 LspC Analogues 10 1.6 Substrate Binding of LspC 11 1.7 Isothermal Titration Calorimetry (ITC) 14 1.8 Experiment Design 17 1.9 ITC Data Analysis 19 2 Results and Discussion 22 2.1 Calcium binding of S1 22 2.2 Ca2+-Dependent C10-P Binding 23 2.3 Interaction between B1 and Calcium 25 2.4 Boron-dependent C10-P Binding 26 2.5 Binding of the Other Ca2+ 28 2.6 Interaction between B1 and PBA 30 2.7 Discussion 32 3 Conclusion 38 4 Experiment Details 40 References 43 Appendix 49 | - |
| dc.language.iso | en | - |
| dc.subject | 拉斯帕托霉素C | zh_TW |
| dc.subject | 受質結合 | zh_TW |
| dc.subject | 香葉基單磷酸 | zh_TW |
| dc.subject | 鈣依賴型抗生素 | zh_TW |
| dc.subject | 苯硼酸 | zh_TW |
| dc.subject | Calcium-dependent antibiotic | en |
| dc.subject | phenylboronic acid | en |
| dc.subject | Laspartomycin C | en |
| dc.subject | substrate binding | en |
| dc.subject | geranyl phosphate | en |
| dc.title | 拉斯帕托霉素C及其相似物與受質結合特性之研究 | zh_TW |
| dc.title | Study on Substrate Binding Characteristics of Laspartomycin C and Its Analogues | en |
| dc.type | Thesis | - |
| dc.date.schoolyear | 112-2 | - |
| dc.description.degree | 碩士 | - |
| dc.contributor.oralexamcommittee | 邱靜雯;陸駿逸;李賢明 | zh_TW |
| dc.contributor.oralexamcommittee | Ching-Wen Chiu;Chun-Yi Lu;Hsien-Ming Lee | en |
| dc.subject.keyword | 鈣依賴型抗生素,拉斯帕托霉素C,苯硼酸,受質結合,香葉基單磷酸, | zh_TW |
| dc.subject.keyword | Calcium-dependent antibiotic,Laspartomycin C,,phenylboronic acid,substrate binding,geranyl phosphate, | en |
| dc.relation.page | 68 | - |
| dc.identifier.doi | 10.6342/NTU202403998 | - |
| dc.rights.note | 同意授權(全球公開) | - |
| dc.date.accepted | 2024-08-12 | - |
| dc.contributor.author-college | 理學院 | - |
| dc.contributor.author-dept | 化學系 | - |
| 顯示於系所單位: | 化學系 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-112-2.pdf | 5.78 MB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
